FONAR PRESS RELEASE NEWS FONAR CORPORATION For Immediate Release The Inventor of MR Scanning Contact: Daniel Culver An ISO 9001 Company Director of Communications Melville, New York 11747 E-mail: investor@fonar.com Phone

Announces Fiscal 2019 3rd Quarter and Nine-Months Financial Results

Revenues - Net increased 9% to $22.8 million, for the third quarter and 7% to $64.7 million for the nine-month period ended

March 31, 2019, versus same period during prior year.

from Operations increased 50% to $6.6 million, for the third quarter and 21% to $18.1 million for the nine-month period ended

March 31, 2019, versus same period during prior year.

Income increased 22% to $ 5.2 million, for the third quarter and 3% to $14.6 million for the nine-month period ended March 31,

2019, versus same period during prior year. This is largely due to net tax adjustments of $1.5 million For the nine months ended

March 31, 2018, the Company recorded a net provision of $3.8 million and

Net Income per Common Share available to Common Shareholders increased 10% to $0.56, for the third quarter,

however it decreased 7% to $1.55 for the nine-month period ended March 31, 2019, versus same period during prior year, as a result

of the Company's requirement to re-evaluate the need for a deferred tax valuation allowance and record a full Provision for Income

Taxes in the amount of $1.5 million for the third quarter and $3.8 million for the nine month period.

scans at the managed or owned centers increased 6% year over year, to 183,000.

Capital increased by 29% to $67.5 million over the first nine-months of Fiscal 2019.

NEW YORK, May 13, 2019 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning , announced today its financial results

for the 3rd Fiscal Quarter of 2019 and the nine-month period ended March 31, 2019. The Company's two industry segments are:

development, manufacturing and servicing of the FONAR UPRIGHT Multi-Position MRI, aka Stand-Up MRI, and management

or ownership of 26 MRI centers through its subsidiary, Health Management Company of America (HMCA).

majority of MRI exams are of the spine, and FONAR's UPRIGHT MRI technology is of great importance. Diagnosticians are

able to view human anatomy in its normal weight-bearing positions, including sitting, standing and bending. Certain anatomical

regions are very sensitive to body-position and gravity. If diagnosticians can evaluate the spine in those positions, they can

minimize or completely avoid the risks of mischaracterizing or underestimating the patients' problems.

increased 9% for the third fiscal quarter ended March 31, 2019 to $22.8 million as compared to $21.0 million for the corresponding

quarter one year earlier. Revenues increased 7% for the nine-month period ended March 31, 2019 to $ 64.5 million as compared to

$60.5 million for the corresponding period one year earlier.

of the reason for this revenue growth was product sales - net increased to $0.8 million from $0.1 million during the third

fiscal quarter ended March 31, 2019.

CORPORATION AND SUBSIDIARIES

from Operations increased 50% for the third fiscal quarter ended March 31, 2019 to $6.7 million as compared to $4.4 million for

the corresponding quarter one year earlier. Income from Operations increased 21% for the nine-month period ended March 31, 2019

to $18.1 million as compared to $15.0 million for the corresponding period one year earlier.

Income increased 22% for the third fiscal quarter ended March 31, 2019 to $5.2 million as compared to $4.3 million for the corresponding

quarter one year earlier. Net Income increased 3% for the nine-month period ended March 31, 2019 to $14.6 million as compared

to $14.1 million for the corresponding period one year earlier, as a result of the Company's requirement to re-evaluate the need

for a deferred tax valuation allowance and record a full Provision for Income Taxes in the amount of $3.8 million.

Provision for Income Taxes increased 828% for the third fiscal quarter ended March 31, 2019 to $1.5 million as compared to $0.2

million for the corresponding quarter one year earlier. The Provision for Income Taxes increased 316% for the nine-month period

ended March 31, 2019 to $3.8 million as compared to $0.9 million for the corresponding period one year earlier. This results from

the re-evaluation of the need for a deferred tax valuation allowance and requirement to record a full tax provision for the nine

months March 31, 2019 in the amount of $3.7 million.

Net Income Per Common Share Available to Common Shareholders increased 10% for the third fiscal quarter ended March 31, 2019 to

$0.56 as compared to $0.51 for the corresponding quarter one year earlier. Diluted Net Income Per Common Share Available to Common

Shareholders decreased 7% for the nine-month period ended March 31, 2019 to $1.55 as compared to $1.66 for the corresponding period

Costs and Expenses decreased 2% for the third fiscal quarter ended March 31, 2019 to $16.2 million as compared to $16.6 million

for the corresponding quarter one year earlier. Total Costs and Expenses increased 2% for the nine-month period ended March 31,

2019 to $46.6 million as compared to $45.5 million for the corresponding period one year earlier.

Cash and Cash Equivalents at March 31, 2019, increased 26% to $24.8 million, as compared to $19.6 million at June 30, 2018.

Assets ended March 31, 2019, increased 7% to $126.6 million, as compared to $118.3 million at June 30, 2018.

Current Assets ended March 31, 2019, increased 18% to $ 78.8 million, as compared to $67.1 million at June 30, 2018.

Liabilities ended March 31, 2019, decreased 21% to $ 12.7 million, as compared to $16.1 million at June 30, 2018.

Current Liabilities ended March 31, 2019, decreased 23% to $ 11.3 million, as compared to $14.6 million at June 30, 2018.

CORPORATION AND SUBSIDIARIES

March 14, 2019, the Company reported in a press release the on-line publication of a chapter where the physician-author-researchers

utilized the FONAR UPRIGHT Multi-Position MRI. The title of their chapter is: Craniocervical Junction Syndrome: Anatomy

of the Craniocervical and Atlantoaxial Junctions and the Effect of Misalignment on Cerebrospinal Fluid Flow.Management

Discussion. To learn more visit: www.fonar.com/news/031419.htm.

of the authors, Dr. Scott Rosa, has developed a patented method to restore cerebrospinal integrity by correcting misalignments

at the cranio-cervical junction (CCJ) called Image Guided Atlas Treatment or IGAT . He says that the FONAR UPRIGHT

MRI and its imaging sequences are a critical part of the IGAT methodology in correcting the misalignments found at the

CCJ. This is because only the FONAR UPRIGHT MRI can visualize the CCJ in the upright, fully weight-loaded position, necessary

for detecting fully distended cerebellar tonsillar ectopia and CSF flow impeding vertebral malalignments.

V. Damadian, M.D., Chairman of the Board of Directors of Fonar Corporation, remarked: "I was very pleased to report that

a central part of this peer-reviewed, research chapter, strongly endorsed the FONAR UPRIGHT Multi-Position MRI. The

chapter reports: The FONAR upright weight-bearing MRI has been shown to be most sensitive in detecting cerebellar tonsillar

ectopia since the weight-bearing posture presents the cerebellar tonsils further distended into the foramen magnum.' In

addition, it recognized that, 'Upright Cine MRI of the cranio-cervical junction demonstrates CSF flow dynamics." These dynamic

studies cannot be obtained on a recumbent-only MRI.

and CEO, Timothy R. Damadian said, "We are very pleased with the third quarter results, in particular the 9% increase in

revenues and the 50% increase in Income from Operations. Eleven (11) of our 26 sites had record scan volumes this quarter.

of our success is attributable to the installation of additional MRI equipment at high-volume centers. The ability to offer referring

physicians a broad spectrum of MRI services together with the cost benefits from shared expenses has resulted in higher profit

margins and record scan volumes at sites in New York and Florida. Encouraged by such performance, we are currently in the process

of installing additional equipment at other high-volume centers.

addition to expanding capacity at existing centers, we have also grown by expanding our footprint with de novo projects.

In fact, we have made the decision to open our eighth location in Florida and expect to have the lease finalized shortly. We continue

to search for acquisitions within our footprint consistent with our business model. While several acquisition opportunities have

arisen over the past six months, none offered our requisite combination of price and growth potential to warrant our use of capital.

the costs involved in purchasing and installing additional equipment, establishing new MRI centers, or making acquisitions are

substantial. With our strong balance sheet, we are grateful to be able to pursue our business plan on a sound financial

Company also sold an UPRIGHT Multi-Position MRI to a new customer in central Florida who had become aware of its enormous

appeal in his community.

cash position, which is now over $24 million, is growing at a significant rate. Along with other strong balance sheet items, the

Company is in excellent position for future growth. Such growth will be well planned and executed in order to maintain the Company's

CORPORATION AND SUBSIDIARIES

The Inventor of MR Scanning , is located in Melville, NY, was incorporated in 1978,

and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial

MRI in 1980, and went public in 1981. FONAR's signature product is the FONAR UPRIGHT Multi-Position MRI (also

known as the Stand-Up MRI), the only whole-body MRI that performs Position Imaging (pMRI ) and scans patients

in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position.

The FONAR UPRIGHT MRI often detects patient problems that other MRI scanners cannot because

they are lie-down and "weightless-only" scanners. The patient-friendly UPRIGHT MRI has a near-zero patient claustrophobic

rejection rate. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic

in my parking lot." Approximately 85% of patients are scanned sitting while watching TV.

has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the

central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column

at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the

body's neurologic system has been made possible first by FONAR's introduction of the MRI and now by this latest works-in-progress

method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients

with whiplash or other neck injuries are among those who will benefit from this new understanding.